These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. FIVB--a new combination of drugs in the treatment of cancer. Van Eden EB, Falkson G, Van der Merwe AM, Van Dyk JJ, Falkson HC. S Afr Med J; 1973 Jun 16; 47(23):982-4. PubMed ID: 4714282 [No Abstract] [Full Text] [Related]
29. Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma. Nathanson L, Wolter J, Horton J, Colsky J, Shnider BI, Schilling A. Clin Pharmacol Ther; 1971 Jun 16; 12(6):955-62. PubMed ID: 5134998 [No Abstract] [Full Text] [Related]
31. [Prophylaxis of asphyxia neonatorum by administration of ethymizol to parturients]. Strukov VA. Akush Ginekol (Mosk); 1973 Nov 16; 49(11):61-3. PubMed ID: 4789582 [No Abstract] [Full Text] [Related]
32. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma. Einhorn LH, McBride CM, Luce JK, Caoili E, Gottlieb JA. Cancer; 1973 Oct 16; 32(4):749-55. PubMed ID: 4751911 [No Abstract] [Full Text] [Related]
34. Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms. Lissoni P, Barni S, Tancini G, Viviani S, Rovelli F, Rescaldani R, Fiorelli G. J Biol Regul Homeost Agents; 1989 Sep 16; 3(3):131-3. PubMed ID: 2560317 [Abstract] [Full Text] [Related]
35. Critical valuation of the subrenal capsule (SRC) assay and its use in experimental therapy. Arnold W, Nowak C, Naundorf H, Kunde D, Wildner GP. Strahlenther Onkol; 1989 Jul 16; 165(7):532-3. PubMed ID: 2546269 [No Abstract] [Full Text] [Related]
36. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma. Moertel CG, Reitemeier RJ, Hahn RG, Schutt AJ. Cancer Chemother Rep; 1970 Dec 16; 54(6):471-3. PubMed ID: 4946016 [No Abstract] [Full Text] [Related]
37. [Transition of criteria for the determination of efficacy of cancer chemotherapy]. Koyama Y. Gan To Kagaku Ryoho; 1986 Jan 16; 13(1):153-63. PubMed ID: 3942397 [No Abstract] [Full Text] [Related]
38. Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma. Braich TA, Salmon SE, Robertone A, Alberts DS, Jones SE, Miller TP, Garewal HS. Invest New Drugs; 1986 Jan 16; 4(3):269-74. PubMed ID: 3818231 [Abstract] [Full Text] [Related]
39. [Experience with weekly intravenous 5-fluorouracil in advanced colonic and rectal neoplasms]. Marcuello Gaspar E, Germa Lluch JR, Abad Esteve A, Badia Canto A. Rev Esp Enferm Apar Dig; 1979 Apr 16; 55(4):365-76. PubMed ID: 493637 [No Abstract] [Full Text] [Related]
40. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma. Ahmann DL, Hahn RG, Bisel HF. Cancer Res; 1972 Nov 16; 32(11):2432-4. PubMed ID: 5082592 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]